Brenntag Partners with DSM-Firmenich on Vitamins
Brenntag SE secured exclusive global distribution rights for DSM-Firmenich's biopharma-grade vitamin portfolio under the new co-brand Byphar. The partnership aims to strengthen availability of critica
Brenntag SE secured exclusive global distribution rights for DSM-Firmenich's biopharma-grade vitamin portfolio under the new co-brand Byphar. The partnership aims to strengthen availability of critica
Kinder Morgan raised its full-year outlook and beat Q2 profit estimates driven by higher natural gas volumes and rising power demand. The company projects adjusted EBITDA 5% higher than planned, fuele
Brenntag SE raised its full-year earnings guidance after Q2 operating EBITDA exceeded estimates at €450 million. Improved margins and robust demand drove the increase, though the company remains cauti
Brenntag CEO Jens Birgersson details how organizational simplification aided response to supply shocks from the Iran war and Strait of Hormuz closure. The crisis triggered volatile pricing and regiona
FirstEnergy reported a 12.5% rise in Q1 profit driven by higher rates and data center demand, while reaffirming a $6 billion 2026 capital investment plan for grid modernization.
Kinder Morgan exceeded Q1 profit expectations driven by increased U.S. natural gas demand due to geopolitical tensions and data center expansion. The company also announced a $505 million acquisition
Gunvor reported an 85% drop in net profits to $104 million in 2025 during its management buyout. The decline included $462 million in writedowns as the firm navigated volatile energy markets and geopo
Brenntag inaugurated a new life sciences innovation and application center in Shanghai to enhance technical expertise for beauty, care, food, and nutrition sectors.
Brenntag reported lower earnings and sales amid a challenging market environment, prompting an increase in its cost-cutting targets. Despite this, the company reaffirmed its stable profit outlook.
Brenntag reported lower 2025 profits and sales in preliminary results, with operating EBITDA missing analyst estimates. The company forecasts flat earnings for 2026.
Brenntag has secured a distribution agreement with Brazil’s Nanum to include graphene nanoplatelets, graphene oxide, and other nanomaterials in its specialty portfolio.
Toyobo reported a substantial profit surge in the first nine months of its fiscal year ending Dec. 31. Earnings from packaging films improved despite weaker cargo movement.
Brenntag has expanded its distribution partnership with Givaudan into Malaysia and Singapore, strengthening its presence in Southeast Asia for beauty ingredients.
Brenntag will continue as title sponsor of the Women in Chemicals annual conference and assume an elevated corporate sponsor role starting in 2026.
Brenntag reported declining earnings and announced further restructuring under its new CEO, who halted plans for a divisional split. While 2025 guidance was lowered to the low end of the range, third-